| Literature DB >> 31534082 |
Kazuaki Fukushima1, Naoki Yanagisawa2,3, Noritaka Sekiya4,5, Hidemasa Izumiya6.
Abstract
Non-typhoidal Salmonella (NTS) infection is a major pathogen causing gastroenteritis among immunocompetent adults. NTS infection is mainly transmitted by contaminated food and water, but some cases are transmitted by animal contact. Salmonella enterica subsp. enterica serovar Poona (S. Poona) is an NTS usually transmitted by reptiles, and cases including outbreaks of gastroenteritis have been reported previously. However, invasive infections due to this organism among immunocompetent adults are rare. We herein report a case of a 39-year-old man who was admitted to our hospital for a fever and headache. Blood cultures were positive for S. Poona, although he did not recall any exposure to reptiles. He was treated successfully with intravenous ceftriaxone without any subsequent complications. This case implies that NTS bacteremia can occur in immunocompetent adults, and the diagnosis may be challenging since there may be no clear exposure or focal physical signs.Entities:
Keywords: Salmonella Poona; bacteremia; immunocompetent adult; non-typhoidal Salmonella
Mesh:
Substances:
Year: 2019 PMID: 31534082 PMCID: PMC7008049 DOI: 10.2169/internalmedicine.3161-19
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Figure 1.Initial abdominal computed tomography revealed mesenteric lymph node swelling and colitis at the ileocecal area. The arrow with the line shows lymph node swelling. The arrow without the line shows colitis at the ascending colon.
Figure 2.Gram stain obtained from blood culture shows Gram-negative bacilli.
Antimicrobial Susceptibility Profile of Salmonella Poona Isolates.
| Drug | Sensitivity | MIC |
|---|---|---|
| Ampicillin (ABPC) | S | <8 |
| Piperacillin (PIPC) | S | <8 |
| Piperacillin/Tazobactam (PIPC/TAZ) | S | <16 |
| Ampicillin/Sulbactam (ABPC/SBT) | S | <8 |
| Cefcapene (CFPN) | S | 1 |
| Cefotaxime (CTX) | S | <1 |
| Cefoperazone/Sulbactam (CPZ/SBT) | S | <16 |
| Flomoxef (FMOX) | S | <8 |
| Cefepime (CFPM) | S | <2 |
| Ceftazidime (CAZ) | S | <4 |
| Ceftriaxone (CTRX) | S | <1 |
| Imipenem (IPM) | S | <1 |
| Meropenem (MEPM) | S | <1 |
| Aztreonam (AZT) | S | <4 |
| Minocycline (MINO) | S | <2 |
| Fosfomycin (FOM) | S | <4 |
| Nalidixic acid (NA) | S | |
| Levofloxacin (LVFX) | S | <0.5 |
| Sulfamethoxazole-Trimethoprim (ST) | S | <2 |
Figure 3.Clinical course of the patient.